Drug intelligence / Profile preview

nanocrystalline megestrol acetate + ondansetron

Development stage
Unknown
Lead developer
AIPING ZHOU
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

A combination therapy consisting of a nanocrystalline formulation of megestrol acetate and the 5-HT3 receptor antagonist ondansetron. Megestrol acetate is a synthetic progestin that, in its nanocrystalline form, exhibits improved bioavailability and is traditionally used to treat anorexia and cachexia. In this clinical study led by Aiping Zhou, it is being evaluated for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastric adenocarcinoma receiving moderately emetogenic chemotherapy (CAPOX plus PD-1/PD-L1 inhibitors). Ondansetron is a standard antiemetic that works by blocking serotonin receptors in the gastrointestinal tract and the central nervous system to inhibit the vomiting reflex.

Other names
nanocrystalline megestrol acetate combined with ondansetron
02

Targets

PR (Progesterone receptor)HTR3A (5-hydroxytryptamine receptor 3A)

Beyond the preview

Go deeper on nanocrystalline megestrol acetate + ondansetron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nanocrystalline megestrol acetate + ondansetron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call